Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors

ClinicalTrials.gov ID: NCT02034708

Public ClinicalTrials.gov record NCT02034708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Intra-individual Cross-over Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/ Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors

Study identification

NCT ID
NCT02034708
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Guerbet
Industry
Enrollment
279 participants

Conditions and interventions

Interventions

  • Dotarem® Drug
  • Gadovist®/Gadavist® Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2014
Primary completion
Aug 31, 2015
Completion
Aug 31, 2015
Last update posted
Dec 29, 2016

2014 – 2015

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama
University of Arizona Medical Center Tucson Arizona AZ 85724
Cedars-Sinai Medical Center Los Angeles California
Yale University School Of Medicine New Haven Connecticut
Infinity Clinical Research, LLC Hollywood Florida FL 33021
University of Michigan Health System Ann Arbor Michigan
Quest Research Institute Farmington Hills Michigan
Spectrum Health Grand Rapids Michigan
Washington University St Louis Missouri
Winthrop University Hospital Clinical Trials Center Mineola New York NY 11501
Temple University Hospital Philadelphia Pennsylvania
MUSC (Medical University of South Carolina) Charleston South Carolina
UVM MRI Center for Biomedical Imaging Burlington Vermont
University of Washington Medical Center Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02034708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 29, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02034708 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →